-
Novavax, Inc. is an
American biotechnology company based in Gaithersburg, Maryland, that
develops vaccines to
counter serious infectious diseases. Prior...
- The
Novavax COVID-19 vaccine, sold
under the
brand names Nuvaxovid and Covovax,
among others, is a
subunit COVID-19
vaccine developed by
Novavax and the...
-
Serum Institute of
India also
reached an
agreement with
Novavax for the
production of
Novavax's NVX-CoV2373 (Covovax)
vaccine for
India and
other low and...
-
vaccines to
stimulate the
immune response. It was
patented in 2020 by
Novavax and is
composed of
nanoparticles from
saponins extracted from Quillaja...
- Oxford–AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin,
Novavax, Convidecia, and Sanofi–GSK.
Seven others are
under ****essment by the WHO:...
- 1007/s12026-018-8991-x. PMC 5899102. "
Novavax COVID-19
Vaccine Demonstrates 89.3%
Efficacy in UK
Phase 3 Trial" (Press release).
Novavax. Jan 28, 2021. "Product Monograph:Arexvy"...
-
through the
COVAX facility under the WHO ho****e. A
recent agreement with
Novavax expands its
production for a
second vaccine to 40
million doses in 2022...
-
initially teamed with
Novavax Inc., a bio-technology
company also
based in Gaithersburg, MD., in the
development and
manufacture of the
Novavax COVID-19 vaccine...
-
November 2022, the
first recombinant protein-based COVID-19
vaccine (
Novavax's booster Nuvaxovid) was
authorised for use in
adults in the
United Kingdom...
- 2020.
Retrieved December 20, 2020. "
Novavax Announces $1.6
Billion Funding from
Operation Warp Speed".
Novavax. July 7, 2020.
Archived from the original...
